Award
Delivery Order #SPE2DP26F2788
Delivery Order for Cefazolin Injection under Long-Term Pharmaceutical Contract
Buyer
Defense Logistics Agency
Award Amount
$72.20
Ceiling
$72.20
Awarded
February 10, 2026
Period of Performance
Feb 10, 2026 – Feb 25, 2026
Identifier
SPE2DP26F2788
NAICS
424210
This contract is a delivery order awarded under a broader indefinite delivery vehicle agreement focusing on pharmaceutical supplies. The recipient, DMS Pharmaceutical Group Inc., is a pharmaceutical distributor known for supplying critical drugs essential to federal health programs. The delivery order specifically procures Cefazolin Injection, an important antibiotic used in various medical treatments. This award supports the agency's ongoing need for reliable and timely access to essential medications, ensuring continuity in healthcare provision. The scope of work involves delivering a specified quantity of Cefazolin Injection within a concise period, highlighting efficient logistics and timely fulfillment. The delivery order was issued under the umbrella of a previously established long-term pharmaceutical supply contract awarded competitively, emphasizing compliance with federal procurement standards. Key performance dates span a short, defined timeframe in early 2026, underscoring the agency’s commitment to prompt drug availability. This action reinforces sustained collaboration between the agency and DMS Pharmaceutical Group Inc. to meet public health requirements.
Description
8511912970!CEFAZOLIN INJECTION